SNSW issued a profit warning, expecting a year-on-year increase of 100.53% in net profit attributable to the parent company for the first three quarters, reaching 145.10 millionZhitong·Oct 13, 2025 at 06:32 AM688117+4.30%
SNSW: Shareholders Chuanfa Investment, Lu Changliang, and Wang Xiaoli plan to collectively reduce their holdings by no more than 3.43%Zhitong·Aug 22, 2025 at 04:24 AM688117+4.30%
SNSW released its semi-annual performance report, with a net profit attributable to the parent company of 88.96 million yuan, a year-on-year increase of 308.29%Zhitong·Aug 14, 2025 at 04:55 AM688117+4.30%
SNSW: Acetate Ganirelix Injection has obtained a drug registration certificateZhitong·Jul 22, 2025 at 04:04 AM688117+4.30%
Hong Kong Stock Concept Tracking | New Commercial Insurance Innovative Drug Directory Added! 2025 Medical Insurance Directory Adjustment Starts, Will Innovative Drugs Welcome a Historic Turning Point? (Including Concept Stocks)Zhitong·Jul 13, 2025 at 06:27 PM688117+4.30%01801-0.96%
The CRO concept surged sharply at the beginning of the session, with ChemPartner rising over 11%, HUIYU PHARMACEUTICAL, SNSW, CTI, and PR all rising over 5%Zhitong·Jul 7, 2025 at 08:37 PM688117+4.30%300012+0.98%
SNSW: Aisena peptide injection has obtained a drug registration certificateZhitong·Jun 30, 2025 at 03:42 AM688117+4.30%
This week, three stocks including Ningbo Huaxiang, SNSW, and Aobo Zhongguang released performance forecasts, among which one stock is expected to see a significant increase in performance, with SNSW's net profit forecast to grow by 332.1% year-on-yearZhitong·Jun 20, 2025 at 09:30 PM688117+4.30%
The chemical pharmaceutical sector sees a short-term surge, ALK hits the limit upZhitong·Jun 19, 2025 at 09:34 PM688266+6.04%300584+2.02%
SNSW issued a profit warning, expecting a year-on-year increase of 253.54% in net profit attributable to the parent company for the first half of the year, reaching 332.1 millionZhitong·Jun 19, 2025 at 04:21 AM688117+4.30%
The innovative drug sector weakened, with individual stocks showing mixed performance. Sinovac Biotech fell over 13%, Warner Pharmaceuticals dropped over 9%, and Xinlitai declined over 8%. SNSW and Kanghong Pharmaceutical both fell over 7%; PKU HEALTHCARE hit the daily limit up, WALVAX rose over 7%, and Zhifei Biological and SMOC increased over 4%Zhitong·Jun 17, 2025 at 12:13 AM688117+4.30%000788+1.17%
The innovative drug sector is partially active, with Hicin Pharmaceutical rising over 10%Zhitong·Jun 5, 2025 at 08:58 PM688062+2.63%002940+3.97%
Weight loss drug concept stocks continue to rise, Kingchem hits the 20% limit upZhitong·May 5, 2025 at 10:10 PM688117+4.30%301092+4.76%
SNSW: Net profit of 50.0237 million yuan in 2024, a year-on-year decrease of 28.88%Zhitong·Apr 24, 2025 at 09:55 AM688117+4.30%
The first quarter report of high-performing stocks is out, with many stocks' net profit growth doubling year-on-yearZhitong·Apr 3, 2025 at 06:53 PM002290+8.41%301127+2.42%
